Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PLX PHARMA INC.

(PLXP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société PLX PHARMA INC.
08/02PLx Pharma Inc.'s VAZALORE to Launch in Nearly 8,000 CVS Stores this Month
GL
07/26PLX PHARMA : VAZALORE to Launch in Over 2,400 Rite Aid Stores in August
AQ
07/22PLX PHARMA : to Discuss 2021 Second Quarter Financial Results on August 6, 2021 ..
AQ
07/19PLx Pharma Inc.'s VAZALORE to Launch in over 8,000 Walgreens Stores Nationwid..
GL
07/12PLX PHARMA : VAZALORE to Launch in over 4,500 Walmart Stores Nationwide in Augus..
AQ
06/09PLx Pharma Inc. to Present at Upcoming Healthcare Industry Conferences
GL
05/14PLX PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
05/14PLX PHARMA INC. : Results of Operations and Financial Condition, Financial State..
AQ
05/14PLx Pharma Inc. Reports First Quarter 2021 Results and Provides Business Upda..
GL
05/03PLx Pharma Inc. to Discuss 2021 First Quarter Financial Results on May 14, 20..
GL
03/17PLX PHARMA INC. : Other Events (form 8-K)
AQ
03/12PLX PHARMA INC. : Results of Operations and Financial Condition, Financial State..
AQ
03/12PLX PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
03/12PLx Pharma Inc. Reports Fourth Quarter and Full Year 2020 Results and Provide..
GL
03/11PLx Pharma Inc. to Present at the Oppenheimer 31st Annual Healthcare Conferen..
GL
03/04PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12,..
GL
03/03PLX PHARMA INC. : Entry into a Material Definitive Agreement, Other Events, Fina..
AQ
03/03PLx Pharma Inc. Prices $63 Million Underwritten Public Offering of Common Sto..
GL
03/02PLX PHARMA INC. : Termination of a Material Definitive Agreement, Results of Ope..
AQ
03/02PLX PHARMA : Announces Proposed Public Offering of Common Stock
AQ
03/01PLX PHARMA : Corporate Presentation
PU
03/01PLX PHARMA INC. : Regulation FD Disclosure, Other Events, Financial Statements a..
AQ
03/01PLx Pharma Receives FDA Approval of SNDAs for Both VAZALORE 325 mg and 81 mg
GL
01/28PLX PHARMA : NAD Rejects Advertiser's Jurisdictional Argument That Claims Were D..
AQ
01/11PLX PHARMA INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020PLX PHARMA INC. : Notice of Delisting or Failure to Satisfy a Continued Listing ..
AQ
2020PLX PHARMA INC. : Entry into a Material Definitive Agreement, Results of Operati..
AQ
2020PLx Pharma Inc. Reports Third Quarter 2020 Results and Provides Business Upda..
GL
2020PLX PHARMA : Reports Third Quarter 2020 Results and Provides Business Update
AQ
2020PLx Pharma Inc. Submits Supplemental New Drug Applications for VAZALORE&trade..
GL
2020PLX PHARMA : Submits Supplemental New Drug Applications for VAZALORE™ 325 ..
AQ
2020PLX PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
2020PLX PHARMA : 2020 Third Quarter Financial Results and Business Update Conference..
AQ
2020PLx Pharma Inc. 2020 Third Quarter Financial Results and Business Update Conf..
GL
2020PLX PHARMA : to Discuss 2020 Third Quarter Financial Results on November 13, 202..
AQ
2020PLx Pharma Inc. to Discuss 2020 Third Quarter Financial Results on November 1..
GL
2020PLX PHARMA INC. : Notice of Delisting or Failure to Satisfy a Continued Listing ..
AQ
2020PLX PHARMA INC. : Regulation FD Disclosure, Financial Statements and Exhibits (f..
AQ
2020PLX PHARMA : to Present Virtually at Oppenheimer Fall Healthcare Life Sciences &..
AQ
2020PLx Pharma Inc. to Present Virtually at Oppenheimer Fall Healthcare Life Scie..
GL
2020PLX PHARMA INC. : Results of Operations and Financial Condition, Shareholder Dir..
AQ
2020PLX PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
2020PLx Pharma Inc. Reports Second Quarter 2020 Results and Provides Business Upd..
GL
2020PLx Pharma Inc. to Discuss 2020 Second Quarter Financial Results on August 14..
GL
2020PLX PHARMA INC. : Material Modification to Rights of Security Holders, Amendment..
AQ
2020PLx Pharma Inc. Announces Completion of $8 Million Convertible Preferred Stoc..
GL
2020PLX PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
2020PLX PHARMA INC. : Results of Operations and Financial Condition (form 8-K)
AQ
2020PLx Pharma Inc. Reports First Quarter 2020 Results
GL
2020PLX PHARMA INC. : Notice of Delisting or Failure to Satisfy a Continued Listing ..
AQ
2020PLx Pharma Inc. to Discuss 2020 First Quarter Financial Results on May 15, 20..
GL
2020PLX PHARMA INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2020PLX PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
2020PLX PHARMA INC. : Entry into a Material Definitive Agreement, Results of Operati..
AQ
2020PLx Pharma Inc. Reports Fourth Quarter 2019 Results and Provides Regulatory U..
GL
2020PLx Pharma Inc. to Discuss 2019 Fourth Quarter and Full Year Financial Result..
GL
2020PLx Pharma Inc. Presents Original Abstract and Simultaneous Publication of it..
GL
2020PLX PHARMA INC. : Regulation FD Disclosure, Financial Statements and Exhibits (f..
AQ
2020PLX PHARMA : to Present at Biotech Showcase 2020
AQ
2020PLx Pharma Inc. to Present at Biotech Showcase 2020
GL
2020PLX PHARMA INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2020PLx Pharma Inc. Provides Regulatory Update on VAZALORE
GL
2019PLX PHARMA : Summary TogglePLx Pharma Inc. Reports Third Quarter 2019 Results
PU
2019PLx Pharma Inc. Reports Third Quarter 2019 Results
GL
2019PLX PHARMA : Summary TogglePLx Pharma Inc. to Discuss 2019 Third Quarter Financi..
PU
2019PLx Pharma Inc. to Discuss 2019 Third Quarter Financial Results on November 8..
GL
2019PLX PHARMA : Summary TogglePLx Pharma Inc. Presents Moderated Abstract and Simul..
PU
2019PLx Pharma Inc. Presents Moderated Abstract and Simultaneous Publication on t..
GL
2019PLX PHARMA : Summary TogglePLx Pharma Inc. to Present at Janney Healthcare Confe..
PU
2019PLx Pharma Inc. to Present at Janney Healthcare Conference 2019 on September ..
GL
2019PLX PHARMA : Summary TogglePLx Pharma Inc. Reports Second Quarter 2019 Results
PU
2019PLx Pharma Inc. Reports Second Quarter 2019 Results
GL
2019PLx Pharma Inc. to Discuss 2019 Second Quarter Financial Results on August 9,..
GL
2019PLX PHARMA : Summary TogglePLx Pharma on Track for VAZALORE Regulatory Pathway
PU
2019PLx Pharma on Track for VAZALORE Regulatory Pathway
GL
1  2Next
Upcoming event on PLX PHARMA INC.